AMRX - Amneal Pharmaceuticals, Inc.
13.02
-0.240 -1.843%
Share volume: 1,048,886
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.24
-0.02%
View ratios
| Fiscal Date | 12-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q4 2025 | |
| Report Date | 02-27-2026 | |
| Assets | ||
| Total Assets | 3.678 B | |
| Current Assets | 1.911 B | |
| Inventories | 606.302 M | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 282.029 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 442.950 M | |
| Other Assets | 1.324 B | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 3.678 B | |
| Total liabilities | 3.672 B | |
| Total current liabilities | 881.633 M | |
| Accounts Payable | 816.801 M | |
| Other liabilities | 98.823 M | |
| Current long term debt | 0.000 | |
| Long term debt | 2.565 B | |
| Other liabilities | 98.823 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | -70.794 M | |
| Common stock | 574.940 M | |
| Retained earnings | -535.005 M |